NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT and 10% CONVERTIBLE PROMISSORY NOTEConsent and Agreement • May 3rd, 2007 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
NORTHWEST BIOTHERAPEUTICS, INC. WARRANTNorthwest Biotherapeutics Inc • May 3rd, 2007 • Pharmaceutical preparations • Delaware
This Certifies That, for value received, Toucan Partners, LLC, with its principal office at 7600 Wisconsin Avenue, Suite 700, Bethesda, MD 20814, and/or its assigns (collectively, the “Holder”), is entitled to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation, with its principal office at 17801 120th Avenue NE, Suite 101, Bothell, Washington 98011 (the “Company”), such number of Exercise Shares as provided herein at the Exercise Price (each subject to adjustment as provided herein). This Warrant is being issued pursuant to the terms of the Amended and Restated Recapitalization Agreement, dated July 30, 2004, as amended on October 22, 2004, November 10, 2004, December 27, 2004, January 26, 2005, April 12, 2005, May 13, 2005, June 16, 2005, July 26, 2005, September 7, 2005 and November 14, 2005, by and among the Company and Toucan Capital Fund II, L.P. (the “Recapitalization Agreement”).
